Annual Revenue
$629.18 M
+$56.23 M+9.81%
31 March 2024
Summary:
Taro Pharmaceutical Industries annual revenue is currently $629.18 million, with the most recent change of +$56.23 million (+9.81%) on 31 March 2024. During the last 3 years, it has risen by +$80.21 million (+14.61%).TARO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$164.94 M
+$7.80 M+4.96%
31 March 2024
Summary:
Taro Pharmaceutical Industries quarterly revenue is currently $164.94 million, with the most recent change of +$7.80 million (+4.96%) on 31 March 2024. Over the past year, it has increased by +$16.74 million (+11.29%).TARO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$629.18 M
+$18.35 M+3.00%
31 March 2024
Summary:
Taro Pharmaceutical Industries TTM revenue is currently $629.18 million, with the most recent change of +$18.35 million (+3.00%) on 31 March 2024. Over the past year, it has increased by +$36.30 million (+6.12%).TARO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.8% | +11.3% | +6.1% |
| 3 y3 years | +14.6% | +25.0% | +10.8% |
| 5 y5 years | -6.1% | +2.5% | -7.3% |
TARO Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -33.8% | -37.8% | -36.2% |
Taro Pharmaceutical Industries Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $629.18 M(+9.8%) | $164.94 M(+5.0%) | $629.18 M(+3.0%) |
| Dec 2023 | - | $157.15 M(+6.0%) | $610.83 M(+3.0%) |
| Sept 2023 | - | $148.20 M(-6.7%) | $592.88 M(+3.1%) |
| June 2023 | - | $158.89 M(+8.4%) | $575.18 M(+0.4%) |
| Mar 2023 | $572.95 M(+2.1%) | $146.59 M(+5.3%) | $572.95 M(+0.6%) |
| Dec 2022 | - | $139.20 M(+6.7%) | $569.63 M(+0.0%) |
| Sept 2022 | - | $130.50 M(-16.7%) | $569.41 M(-0.3%) |
| June 2022 | - | $156.66 M(+9.4%) | $570.90 M(+1.7%) |
| Mar 2022 | $561.35 M(+2.3%) | $143.26 M(+3.1%) | $561.35 M(-0.9%) |
| Dec 2021 | - | $138.98 M(+5.3%) | $566.43 M(-0.2%) |
| Sept 2021 | - | $131.99 M(-10.3%) | $567.59 M(-1.9%) |
| June 2021 | - | $147.11 M(-0.8%) | $578.45 M(+5.4%) |
| Mar 2021 | $548.97 M(-14.9%) | $148.35 M(+5.9%) | $548.97 M(-4.6%) |
| Dec 2020 | - | $140.15 M(-1.9%) | $575.56 M(-1.3%) |
| Sept 2020 | - | $142.84 M(+21.4%) | $583.10 M(-3.0%) |
| June 2020 | - | $117.63 M(-32.8%) | $601.11 M(-6.8%) |
| Mar 2020 | $644.77 M(-3.8%) | $174.94 M(+18.5%) | $644.77 M(-0.8%) |
| Dec 2019 | - | $147.68 M(-8.2%) | $649.75 M(-4.2%) |
| Sept 2019 | - | $160.85 M(-0.3%) | $678.45 M(+0.3%) |
| June 2019 | - | $161.30 M(-10.4%) | $676.57 M(+1.0%) |
| Mar 2019 | $669.89 M(+1.2%) | $179.92 M(+2.0%) | $669.89 M(+0.7%) |
| Dec 2018 | - | $176.38 M(+11.0%) | $665.19 M(+3.2%) |
| Sept 2018 | - | $158.97 M(+2.8%) | $644.27 M(-1.7%) |
| June 2018 | - | $154.62 M(-11.8%) | $655.21 M(-1.0%) |
| Mar 2018 | $661.91 M(-24.7%) | $175.22 M(+12.7%) | $661.91 M(-3.1%) |
| Dec 2017 | - | $155.46 M(-8.5%) | $683.11 M(-8.7%) |
| Sept 2017 | - | $169.91 M(+5.3%) | $748.04 M(-7.3%) |
| June 2017 | - | $161.32 M(-17.9%) | $806.92 M(-8.2%) |
| Mar 2017 | $879.39 M(-7.5%) | $196.41 M(-10.9%) | $879.39 M(-7.2%) |
| Dec 2016 | - | $220.40 M(-3.7%) | $948.05 M(-3.8%) |
| Sept 2016 | - | $228.79 M(-2.1%) | $985.99 M(+1.7%) |
| June 2016 | - | $233.78 M(-11.8%) | $969.26 M(+1.9%) |
| Mar 2016 | $950.75 M(+10.2%) | $265.07 M(+2.6%) | $950.75 M(+2.2%) |
| Dec 2015 | - | $258.34 M(+21.8%) | $929.86 M(+2.3%) |
| Sept 2015 | - | $212.06 M(-1.5%) | $909.22 M(-4.1%) |
| June 2015 | - | $215.28 M(-11.8%) | $947.99 M(+9.9%) |
| Mar 2015 | $862.94 M(+13.7%) | $244.18 M(+2.7%) | $862.94 M(+7.1%) |
| Dec 2014 | - | $237.70 M(-5.2%) | $805.94 M(+3.1%) |
| Sept 2014 | - | $250.83 M(+92.6%) | $781.84 M(+6.2%) |
| June 2014 | - | $130.23 M(-30.4%) | $736.32 M(-3.0%) |
| Mar 2014 | $759.28 M(+13.2%) | $187.18 M(-12.4%) | $759.28 M(+3.0%) |
| Dec 2013 | - | $213.60 M(+4.0%) | $737.24 M(+3.9%) |
| Sept 2013 | - | $205.32 M(+34.0%) | $709.34 M(+6.7%) |
| June 2013 | - | $153.19 M(-7.2%) | $665.00 M(-0.9%) |
| Mar 2013 | $670.95 M(+362.3%) | $165.13 M(-11.1%) | $670.95 M(+3.1%) |
| Dec 2012 | - | $185.69 M(+15.4%) | $650.96 M(+6.1%) |
| Sept 2012 | - | $160.97 M(+1.1%) | $613.37 M(+3.8%) |
| June 2012 | - | $159.15 M(+9.7%) | $590.65 M(+8.8%) |
| Mar 2012 | $145.14 M(-71.3%) | $145.14 M(-2.0%) | $543.08 M(+7.4%) |
| Dec 2011 | $505.67 M(+28.8%) | $148.10 M(+7.1%) | $505.67 M(+9.9%) |
| Sept 2011 | - | $138.25 M(+23.9%) | $460.22 M(+8.3%) |
| June 2011 | - | $111.58 M(+3.6%) | $425.05 M(+3.4%) |
| Mar 2011 | - | $107.73 M(+4.9%) | $411.22 M(+4.8%) |
| Dec 2010 | $392.54 M(+10.3%) | $102.65 M(-0.4%) | $392.54 M(+6.0%) |
| Sept 2010 | - | $103.09 M(+5.5%) | $370.25 M(+2.6%) |
| June 2010 | - | $97.75 M(+9.8%) | $361.02 M(+0.3%) |
| Mar 2010 | - | $89.04 M(+10.8%) | $360.09 M(+1.2%) |
| Dec 2009 | $355.94 M(+8.2%) | $80.37 M(-14.4%) | $355.94 M(+2.3%) |
| Sept 2009 | - | $93.86 M(-3.1%) | $347.96 M(+1.0%) |
| June 2009 | - | $96.82 M(+14.0%) | $344.55 M(+2.6%) |
| Mar 2009 | - | $84.89 M(+17.3%) | $335.87 M(+33.8%) |
| Dec 2008 | $329.04 M(+3.0%) | $72.40 M(-19.9%) | $250.98 M(+40.5%) |
| Sept 2008 | - | $90.44 M(+2.6%) | $178.58 M(+102.6%) |
| June 2008 | - | $88.14 M(+39.2%) | $88.14 M(-69.9%) |
| Dec 2007 | $319.55 M(+26.7%) | - | - |
| Dec 2006 | $252.27 M(-12.6%) | - | - |
| Dec 2005 | $288.62 M(+1.6%) | $63.33 M(-12.7%) | $292.98 M(-4.7%) |
| Sept 2005 | - | $72.54 M(-7.7%) | $307.32 M(-0.2%) |
| June 2005 | - | $78.57 M(+0.0%) | $308.06 M(+10.6%) |
| Mar 2005 | - | $78.54 M(+1.1%) | $278.59 M(-1.9%) |
| Dec 2004 | $284.13 M | $77.67 M(+6.0%) | $284.13 M(-3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2004 | - | $73.28 M(+49.2%) | $295.08 M(-3.2%) |
| June 2004 | - | $49.10 M(-41.6%) | $304.92 M(-7.8%) |
| Mar 2004 | - | $84.08 M(-5.1%) | $330.57 M(+4.8%) |
| Dec 2003 | $315.46 M(+49.1%) | $88.62 M(+6.6%) | $315.46 M(+9.2%) |
| Sept 2003 | - | $83.11 M(+11.2%) | $288.81 M(+10.6%) |
| June 2003 | - | $74.75 M(+8.4%) | $261.18 M(+10.7%) |
| Mar 2003 | - | $68.97 M(+11.3%) | $236.01 M(+11.5%) |
| Dec 2002 | $211.58 M(+41.8%) | $61.98 M(+11.7%) | $211.58 M(+9.8%) |
| Sept 2002 | - | $55.48 M(+11.9%) | $192.71 M(+7.9%) |
| June 2002 | - | $49.58 M(+11.3%) | $178.62 M(+8.0%) |
| Mar 2002 | - | $44.54 M(+3.3%) | $165.40 M(+10.8%) |
| Dec 2001 | $149.23 M(+43.8%) | $43.11 M(+4.1%) | $149.23 M(+9.7%) |
| Sept 2001 | - | $41.39 M(+13.8%) | $136.07 M(+11.6%) |
| June 2001 | - | $36.36 M(+28.2%) | $121.88 M(+10.9%) |
| Mar 2001 | - | $28.37 M(-5.3%) | $109.93 M(+5.9%) |
| Dec 2000 | $103.80 M(+23.9%) | $29.95 M(+10.1%) | $103.80 M(+8.0%) |
| Sept 2000 | - | $27.20 M(+11.4%) | $96.13 M(+5.6%) |
| June 2000 | - | $24.41 M(+9.8%) | $90.99 M(+3.9%) |
| Mar 2000 | - | $22.23 M(-0.2%) | $87.58 M(+4.5%) |
| Dec 1999 | $83.78 M(+25.6%) | $22.28 M(+1.0%) | $83.78 M(+3.1%) |
| Sept 1999 | - | $22.07 M(+5.1%) | $81.23 M(+6.4%) |
| June 1999 | - | $21.00 M(+13.9%) | $76.36 M(+6.6%) |
| Mar 1999 | - | $18.43 M(-6.6%) | $71.66 M(+7.4%) |
| Dec 1998 | $66.72 M(+9.4%) | $19.73 M(+14.7%) | $66.72 M(+5.8%) |
| Sept 1998 | - | $17.20 M(+5.5%) | $63.07 M(+0.8%) |
| June 1998 | - | $16.30 M(+20.7%) | $62.57 M(+1.1%) |
| Mar 1998 | - | $13.50 M(-16.0%) | $61.87 M(+1.3%) |
| Dec 1997 | $60.97 M(+7.9%) | $16.07 M(-3.8%) | $61.07 M(+1.8%) |
| Sept 1997 | - | $16.70 M(+7.1%) | $60.00 M(+3.4%) |
| June 1997 | - | $15.60 M(+22.8%) | $58.00 M(+2.7%) |
| Mar 1997 | - | $12.70 M(-15.3%) | $56.50 M(0.0%) |
| Dec 1996 | $56.50 M(+13.9%) | $15.00 M(+2.0%) | $56.50 M(+4.6%) |
| Sept 1996 | - | $14.70 M(+4.3%) | $54.00 M(+3.6%) |
| June 1996 | - | $14.10 M(+11.0%) | $52.10 M(+2.0%) |
| Mar 1996 | - | $12.70 M(+1.6%) | $51.10 M(+3.0%) |
| Dec 1995 | $49.60 M(+17.8%) | $12.50 M(-2.3%) | $49.60 M(-1.2%) |
| Sept 1995 | - | $12.80 M(-2.3%) | $50.20 M(+6.1%) |
| June 1995 | - | $13.10 M(+17.0%) | $47.30 M(+7.0%) |
| Mar 1995 | - | $11.20 M(-14.5%) | $44.20 M(+5.0%) |
| Dec 1994 | $42.10 M(+47.7%) | $13.10 M(+32.3%) | $42.10 M(+14.1%) |
| Sept 1994 | - | $9.90 M(-1.0%) | $36.90 M(+10.5%) |
| June 1994 | - | $10.00 M(+9.9%) | $33.40 M(+7.7%) |
| Mar 1994 | - | $9.10 M(+15.2%) | $31.00 M(+8.8%) |
| Dec 1993 | $28.50 M(+7.5%) | $7.90 M(+23.4%) | $28.50 M(+2.5%) |
| Sept 1993 | - | $6.40 M(-15.8%) | $27.80 M(-2.8%) |
| June 1993 | - | $7.60 M(+15.2%) | $28.60 M(+4.4%) |
| Mar 1993 | - | $6.60 M(-8.3%) | $27.40 M(+3.4%) |
| Dec 1992 | $26.50 M(+28.6%) | $7.20 M(0.0%) | $26.50 M(+6.0%) |
| Sept 1992 | - | $7.20 M(+12.5%) | $25.00 M(+5.5%) |
| June 1992 | - | $6.40 M(+12.3%) | $23.70 M(+7.7%) |
| Mar 1992 | - | $5.70 M(0.0%) | $22.00 M(+5.8%) |
| Dec 1991 | $20.60 M(+54.9%) | $5.70 M(-3.4%) | $20.80 M(+10.1%) |
| Sept 1991 | - | $5.90 M(+25.5%) | $18.90 M(+16.0%) |
| June 1991 | - | $4.70 M(+4.4%) | $16.30 M(+9.4%) |
| Mar 1991 | - | $4.50 M(+18.4%) | $14.90 M(+12.9%) |
| Dec 1990 | $13.30 M(+12.7%) | $3.80 M(+15.2%) | $13.20 M(+4.8%) |
| Sept 1990 | - | $3.30 M(0.0%) | $12.60 M(-0.8%) |
| June 1990 | - | $3.30 M(+17.9%) | $12.70 M(+5.0%) |
| Mar 1990 | - | $2.80 M(-12.5%) | $12.10 M(+1.7%) |
| Dec 1989 | $11.80 M(+28.3%) | $3.20 M(-5.9%) | $11.90 M(+13.3%) |
| Sept 1989 | - | $3.40 M(+25.9%) | $10.50 M(+14.1%) |
| June 1989 | - | $2.70 M(+3.8%) | $9.20 M(+1.1%) |
| Mar 1989 | - | $2.60 M(+44.4%) | $9.10 M(+2.2%) |
| Dec 1988 | $9.20 M(+4.5%) | $1.80 M(-14.3%) | $8.90 M(-10.1%) |
| Sept 1988 | - | $2.10 M(-19.2%) | $9.90 M(+1.0%) |
| June 1988 | - | $2.60 M(+8.3%) | $9.80 M(+6.5%) |
| Mar 1988 | - | $2.40 M(-14.3%) | $9.20 M(+4.5%) |
| Dec 1987 | $8.80 M | $2.80 M(+40.0%) | $8.80 M(+46.7%) |
| Sept 1987 | - | $2.00 M(0.0%) | $6.00 M(+50.0%) |
| June 1987 | - | $2.00 M(0.0%) | $4.00 M(+100.0%) |
| Mar 1987 | - | $2.00 M | $2.00 M |
FAQ
- What is Taro Pharmaceutical Industries annual revenue?
- What is the all time high annual revenue for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual revenue year-on-year change?
- What is Taro Pharmaceutical Industries quarterly revenue?
- What is the all time high quarterly revenue for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly revenue year-on-year change?
- What is Taro Pharmaceutical Industries TTM revenue?
- What is the all time high TTM revenue for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries TTM revenue year-on-year change?
What is Taro Pharmaceutical Industries annual revenue?
The current annual revenue of TARO is $629.18 M
What is the all time high annual revenue for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual revenue is $950.75 M
What is Taro Pharmaceutical Industries annual revenue year-on-year change?
Over the past year, TARO annual revenue has changed by +$56.23 M (+9.81%)
What is Taro Pharmaceutical Industries quarterly revenue?
The current quarterly revenue of TARO is $164.94 M
What is the all time high quarterly revenue for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly revenue is $265.07 M
What is Taro Pharmaceutical Industries quarterly revenue year-on-year change?
Over the past year, TARO quarterly revenue has changed by +$16.74 M (+11.29%)
What is Taro Pharmaceutical Industries TTM revenue?
The current TTM revenue of TARO is $629.18 M
What is the all time high TTM revenue for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high TTM revenue is $985.99 M
What is Taro Pharmaceutical Industries TTM revenue year-on-year change?
Over the past year, TARO TTM revenue has changed by +$36.30 M (+6.12%)